Victoza vs Zepbound
Drug comparison
Last updated 2026-05-28 15:46 UTCVictoza (liraglutide) is a once-daily injection made by Novo Nordisk for treating type 2 diabetes and reducing cardiovascular risk. Zepbound (tirzepatide), from Eli Lilly, is also given by injection but is approved for obesity and obstructive sleep apnea. Both are taken under the skin, but Victoza is used for blood sugar control while Zepbound targets weight management and sleep-related breathing issues.
AI summary of the sources below.
| Victoza | Zepbound | |
|---|---|---|
| Active ingredient | liraglutide | tirzepatide |
| Manufacturer | novo-nordisk | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes, cardiovascular risk reduction | obesity, obstructive sleep apnea |
| Label updated | 2023-02-06 | 2026-04-22 |